首页 > 最新文献

BMC Cancer最新文献

英文 中文
MMP1 is a promising prognostic, therapeutic and immunological biomarker for pancreatic cancer: evidence from bioinformatics analysis and biological experiments. MMP1是一种有前景的胰腺癌预后、治疗和免疫生物标志物:来自生物信息学分析和生物学实验的证据。
IF 3.4 2区 医学 Q2 ONCOLOGY Pub Date : 2026-02-12 DOI: 10.1186/s12885-026-15685-0
Shuhui Wang, Kaini He, Mimi Liu, Jiaxuan Zhou, Yujie Wen, Yan Cheng
{"title":"MMP1 is a promising prognostic, therapeutic and immunological biomarker for pancreatic cancer: evidence from bioinformatics analysis and biological experiments.","authors":"Shuhui Wang, Kaini He, Mimi Liu, Jiaxuan Zhou, Yujie Wen, Yan Cheng","doi":"10.1186/s12885-026-15685-0","DOIUrl":"https://doi.org/10.1186/s12885-026-15685-0","url":null,"abstract":"","PeriodicalId":9131,"journal":{"name":"BMC Cancer","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146177884","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pretreatment clinical and hematological predictors of efficacy and immune-related adverse events in patients with advanced non-small cell lung cancer receiving first-line chemotherapy combined with immune checkpoint inhibitors. 接受一线化疗联合免疫检查点抑制剂的晚期非小细胞肺癌患者的疗效和免疫相关不良事件的预处理临床和血液学预测因子
IF 3.4 2区 医学 Q2 ONCOLOGY Pub Date : 2026-02-12 DOI: 10.1186/s12885-026-15733-9
Shun Matsuura, Kensuke Kita, Kyohei Matsushita, Takumi Nagasaki, Ryo Suzuki, Yuya Yamamoto, Kotaro Yamada, Ryuuichi Nakamura, Norimichi Akiyama, Kazuki Tanaka, Naoki Koshimizu
{"title":"Pretreatment clinical and hematological predictors of efficacy and immune-related adverse events in patients with advanced non-small cell lung cancer receiving first-line chemotherapy combined with immune checkpoint inhibitors.","authors":"Shun Matsuura, Kensuke Kita, Kyohei Matsushita, Takumi Nagasaki, Ryo Suzuki, Yuya Yamamoto, Kotaro Yamada, Ryuuichi Nakamura, Norimichi Akiyama, Kazuki Tanaka, Naoki Koshimizu","doi":"10.1186/s12885-026-15733-9","DOIUrl":"https://doi.org/10.1186/s12885-026-15733-9","url":null,"abstract":"","PeriodicalId":9131,"journal":{"name":"BMC Cancer","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146177837","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Integrated analysis of miR-15a-5p, miR-20a-5p, and miR-33b-3p identifies EGR2-associated biomarkers in multiple myeloma. 对miR-15a-5p、miR-20a-5p和miR-33b-3p的综合分析确定了多发性骨髓瘤中egr2相关的生物标志物。
IF 3.4 2区 医学 Q2 ONCOLOGY Pub Date : 2026-02-12 DOI: 10.1186/s12885-026-15610-5
Riham Abdel-Hamid Haroun, Nada M Ismail, Samar S Elshazly, Fatma F Abdel Hamid, Reem Nabil
{"title":"Integrated analysis of miR-15a-5p, miR-20a-5p, and miR-33b-3p identifies EGR2-associated biomarkers in multiple myeloma.","authors":"Riham Abdel-Hamid Haroun, Nada M Ismail, Samar S Elshazly, Fatma F Abdel Hamid, Reem Nabil","doi":"10.1186/s12885-026-15610-5","DOIUrl":"https://doi.org/10.1186/s12885-026-15610-5","url":null,"abstract":"","PeriodicalId":9131,"journal":{"name":"BMC Cancer","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146177881","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessing the covariates of delay in seeking health care among patients with oral and oropharyngeal squamous cell carcinoma in Tanzania. 评估坦桑尼亚口腔和口咽鳞状细胞癌患者延迟就医的协变量。
IF 3.4 2区 医学 Q2 ONCOLOGY Pub Date : 2026-02-12 DOI: 10.1186/s12885-026-15572-8
Sira Stanslaus Owibingire, Irene Kida Minja, Elison Nathaniel Simon, Daniela Elena Costea, Anne Nordrehaug Astrom
{"title":"Assessing the covariates of delay in seeking health care among patients with oral and oropharyngeal squamous cell carcinoma in Tanzania.","authors":"Sira Stanslaus Owibingire, Irene Kida Minja, Elison Nathaniel Simon, Daniela Elena Costea, Anne Nordrehaug Astrom","doi":"10.1186/s12885-026-15572-8","DOIUrl":"https://doi.org/10.1186/s12885-026-15572-8","url":null,"abstract":"","PeriodicalId":9131,"journal":{"name":"BMC Cancer","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146164186","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and safety of 50 mg versus 100 mg daily frontline dasatinib therapy in chronic-phase chronic myeloid leukemia: a non-controlled, observational dose-comparative cohort study. 每日50 mg与100 mg达沙替尼一线治疗慢性粒细胞白血病的疗效和安全性:一项非对照、观察性剂量比较队列研究
IF 3.4 2区 医学 Q2 ONCOLOGY Pub Date : 2026-02-11 DOI: 10.1186/s12885-026-15719-7
Fang Cheng, Fan Wang, Zheng Cui, Qiang Li, Yu Zhu, Weiming Li
{"title":"Efficacy and safety of 50 mg versus 100 mg daily frontline dasatinib therapy in chronic-phase chronic myeloid leukemia: a non-controlled, observational dose-comparative cohort study.","authors":"Fang Cheng, Fan Wang, Zheng Cui, Qiang Li, Yu Zhu, Weiming Li","doi":"10.1186/s12885-026-15719-7","DOIUrl":"https://doi.org/10.1186/s12885-026-15719-7","url":null,"abstract":"","PeriodicalId":9131,"journal":{"name":"BMC Cancer","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146156014","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mechanism of action of MiR-330-5p targeting ITGA5 in the regulation of proliferation, migration, and invasionof gastric cancer. 靶向ITGA5的MiR-330-5p调控胃癌增殖、迁移和侵袭的作用机制
IF 3.4 2区 医学 Q2 ONCOLOGY Pub Date : 2026-02-11 DOI: 10.1186/s12885-026-15676-1
Jun-Fu Wang, Jian-Ming Wei, Ting He, Jun-Wen Hu, Jiang-Nan Zhang, Long-Zi Liu

Background: ITGA5 is an oncogene that performs its biological function by integrating the intracellular structure and extracellular matrix. We found that ITGA5 is highly expressed in gastric tumors and is closely related to proliferation and metastasis. Multiple miRNAs regulate the ITGA5 gene during the occurrence and development of tumors. This study aimed to explore the role of targeting miRNAs upstream of ITGA5 in the regulation of the proliferation, invasion, and migration of gastric cancer cells.

Methods: Target miRNA molecules regulating the ITGA5 gene were predicted using four bioinformatics databases (TargetScan、miRDB、miRTarBase and mirDIP). The unreported miRNAs with high correlation were selected, and their expression in gastric cancer was assessed using qRT-PCR and western blot. The miRNAs with potential targeting abilities were further verified by dual luciferase reporter gene experiment. The effects of miR-330-5p and ITGA5 on the proliferation, invasion, and migration of gastric cancer cells were evaluated using CCK8, clonogenic assay, and Transwell chamber assay, respectively.

Results: Six miRNAs (miR-26a-5p、miR-92a-3p、miR-148a-3p、miR-148b-3p、miR-330-5p and miR-152-3p) were identified. miR-330-5p was found to target and regulate ITGA5. In vitro experiments demonstrated that miR-330-5p mimic significantly inhibited the proliferation, invasion, and migration of gastric cancer cells compared with the control group (p < 0.05). Transfection of miR-330-5p mimic into gastric cancer cells overexpressing ITGA5 (OE-ITGA5) significantly prevented the ability of OE-ITGA5 to promote the proliferation, invasion, and migration of gastric cancer cells (P < 0.05). In addition, miR-330-5p mimic reduced ITGA5 expression in gastric cancer cells and partially prevented FAK/AKT signaling pathway activated by the ITGA5 gene. An miR-330-5p inhibitor increased ITGA5 expression in gastric cancer cells, and partially prevented blockage of the FAK/AKT signaling pathway by sh-ITGA5.

Conclusions: miR-330-5p was shown to affect the proliferation, invasion, and migration of gastric cancer cells by mediating ITGA5 through a mechanism possibly associated with the regulation of the FAK/AKT signaling pathway.

背景:ITGA5是一种通过整合细胞内结构和细胞外基质来发挥其生物学功能的致癌基因。我们发现ITGA5在胃肿瘤中高表达,与肿瘤的增殖和转移密切相关。在肿瘤的发生和发展过程中,有多种mirna调控ITGA5基因。本研究旨在探讨ITGA5上游靶向miRNAs在胃癌细胞增殖、侵袭和迁移调控中的作用。方法:利用TargetScan、miRDB、miRTarBase和mirDIP四个生物信息学数据库预测ITGA5基因调控的靶miRNA分子。选择未报道的高相关性mirna,采用qRT-PCR和western blot检测其在胃癌中的表达情况。双荧光素酶报告基因实验进一步验证了具有潜在靶向能力的mirna。采用CCK8、克隆实验和Transwell室实验分别评价miR-330-5p和ITGA5对胃癌细胞增殖、侵袭和迁移的影响。结果:共鉴定出6种miRNAs (miR-26a-5p、miR-92a-3p、miR-148a-3p、miR-148b-3p、miR-330-5p和miR-152-3p)。发现miR-330-5p靶向并调节ITGA5。体外实验表明,与对照组相比,miR-330-5p mimic显著抑制了胃癌细胞的增殖、侵袭和迁移(p结论:miR-330-5p通过介导ITGA5影响胃癌细胞的增殖、侵袭和迁移,其机制可能与调节FAK/AKT信号通路有关。
{"title":"Mechanism of action of MiR-330-5p targeting ITGA5 in the regulation of proliferation, migration, and invasionof gastric cancer.","authors":"Jun-Fu Wang, Jian-Ming Wei, Ting He, Jun-Wen Hu, Jiang-Nan Zhang, Long-Zi Liu","doi":"10.1186/s12885-026-15676-1","DOIUrl":"https://doi.org/10.1186/s12885-026-15676-1","url":null,"abstract":"<p><strong>Background: </strong>ITGA5 is an oncogene that performs its biological function by integrating the intracellular structure and extracellular matrix. We found that ITGA5 is highly expressed in gastric tumors and is closely related to proliferation and metastasis. Multiple miRNAs regulate the ITGA5 gene during the occurrence and development of tumors. This study aimed to explore the role of targeting miRNAs upstream of ITGA5 in the regulation of the proliferation, invasion, and migration of gastric cancer cells.</p><p><strong>Methods: </strong>Target miRNA molecules regulating the ITGA5 gene were predicted using four bioinformatics databases (TargetScan、miRDB、miRTarBase and mirDIP). The unreported miRNAs with high correlation were selected, and their expression in gastric cancer was assessed using qRT-PCR and western blot. The miRNAs with potential targeting abilities were further verified by dual luciferase reporter gene experiment. The effects of miR-330-5p and ITGA5 on the proliferation, invasion, and migration of gastric cancer cells were evaluated using CCK8, clonogenic assay, and Transwell chamber assay, respectively.</p><p><strong>Results: </strong>Six miRNAs (miR-26a-5p、miR-92a-3p、miR-148a-3p、miR-148b-3p、miR-330-5p and miR-152-3p) were identified. miR-330-5p was found to target and regulate ITGA5. In vitro experiments demonstrated that miR-330-5p mimic significantly inhibited the proliferation, invasion, and migration of gastric cancer cells compared with the control group (p < 0.05). Transfection of miR-330-5p mimic into gastric cancer cells overexpressing ITGA5 (OE-ITGA5) significantly prevented the ability of OE-ITGA5 to promote the proliferation, invasion, and migration of gastric cancer cells (P < 0.05). In addition, miR-330-5p mimic reduced ITGA5 expression in gastric cancer cells and partially prevented FAK/AKT signaling pathway activated by the ITGA5 gene. An miR-330-5p inhibitor increased ITGA5 expression in gastric cancer cells, and partially prevented blockage of the FAK/AKT signaling pathway by sh-ITGA5.</p><p><strong>Conclusions: </strong>miR-330-5p was shown to affect the proliferation, invasion, and migration of gastric cancer cells by mediating ITGA5 through a mechanism possibly associated with the regulation of the FAK/AKT signaling pathway.</p>","PeriodicalId":9131,"journal":{"name":"BMC Cancer","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146164233","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surufatinib plus tislelizumab as later-line therapy for metastatic colorectal cancer: a single-arm, phase II trial. 舒法替尼联合替利单抗作为转移性结直肠癌的后期治疗:单组II期试验
IF 3.4 2区 医学 Q2 ONCOLOGY Pub Date : 2026-02-11 DOI: 10.1186/s12885-026-15705-z
Huijun Xu, Ying Yan, JiaYu Niu, Lulu Cao, Wenju Chen, Mengge Li, Huiqin Luo, Lihong Ke, Shusheng Wu, Gang Wang, Yifu He
{"title":"Surufatinib plus tislelizumab as later-line therapy for metastatic colorectal cancer: a single-arm, phase II trial.","authors":"Huijun Xu, Ying Yan, JiaYu Niu, Lulu Cao, Wenju Chen, Mengge Li, Huiqin Luo, Lihong Ke, Shusheng Wu, Gang Wang, Yifu He","doi":"10.1186/s12885-026-15705-z","DOIUrl":"https://doi.org/10.1186/s12885-026-15705-z","url":null,"abstract":"","PeriodicalId":9131,"journal":{"name":"BMC Cancer","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146164168","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Machine learning-based prediction of long-term prognosis in cervical adenocarcinoma: a retrospective cohort study. 基于机器学习的宫颈腺癌长期预后预测:一项回顾性队列研究。
IF 3.4 2区 医学 Q2 ONCOLOGY Pub Date : 2026-02-11 DOI: 10.1186/s12885-026-15730-y
Gangfeng Zhu, Cixiang Chen, Yi Xiang, Yili Wang, Linyu Zhong, Zenghong Lu
{"title":"Machine learning-based prediction of long-term prognosis in cervical adenocarcinoma: a retrospective cohort study.","authors":"Gangfeng Zhu, Cixiang Chen, Yi Xiang, Yili Wang, Linyu Zhong, Zenghong Lu","doi":"10.1186/s12885-026-15730-y","DOIUrl":"https://doi.org/10.1186/s12885-026-15730-y","url":null,"abstract":"","PeriodicalId":9131,"journal":{"name":"BMC Cancer","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146164202","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Increased cytoplasmic and nuclear S100A6 expression is associated with improved prognosis in ovarian cancer. 细胞质和细胞核S100A6表达增加与卵巢癌预后改善相关。
IF 3.4 2区 医学 Q2 ONCOLOGY Pub Date : 2026-02-11 DOI: 10.1186/s12885-026-15631-0
Aruba Farooq, Evren M Akyuz, Brandon Wq Cheah, Suha Deen, Stewart G Martin, Mattéa J Finelli, Sarah Storr, Alan McIntyre
{"title":"Increased cytoplasmic and nuclear S100A6 expression is associated with improved prognosis in ovarian cancer.","authors":"Aruba Farooq, Evren M Akyuz, Brandon Wq Cheah, Suha Deen, Stewart G Martin, Mattéa J Finelli, Sarah Storr, Alan McIntyre","doi":"10.1186/s12885-026-15631-0","DOIUrl":"https://doi.org/10.1186/s12885-026-15631-0","url":null,"abstract":"","PeriodicalId":9131,"journal":{"name":"BMC Cancer","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146164199","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A multi-branch ensemble learning framework for detection of non-small cell lung cancer via T-cell receptor sequencing. 通过t细胞受体测序检测非小细胞肺癌的多分支集成学习框架。
IF 3.4 2区 医学 Q2 ONCOLOGY Pub Date : 2026-02-11 DOI: 10.1186/s12885-026-15714-y
Wenjian Wang, Xueting Hu, Yi Luan, Wenzeng Chen, Qinxuan Zhu, Guiping Tian, Qihao Zheng, Jing Meng, Chuan Wang, Minghui Wang
{"title":"A multi-branch ensemble learning framework for detection of non-small cell lung cancer via T-cell receptor sequencing.","authors":"Wenjian Wang, Xueting Hu, Yi Luan, Wenzeng Chen, Qinxuan Zhu, Guiping Tian, Qihao Zheng, Jing Meng, Chuan Wang, Minghui Wang","doi":"10.1186/s12885-026-15714-y","DOIUrl":"https://doi.org/10.1186/s12885-026-15714-y","url":null,"abstract":"","PeriodicalId":9131,"journal":{"name":"BMC Cancer","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146164256","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
BMC Cancer
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1